CLINICAL_TRIALS
trial_result
· 2022-05-06
Clinical Trial Update: Single-Dose Administration Trial of TLC599 in Osteoarthritis of the Knee [Phase 1, Phase 2]
Summary
Clinical trial update for a single-dose TLC599 in osteoarthritis of the knee shows completed Phase 1/2 study with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Taiwan Liposome Company | Conditions: Osteoarthritis of the Knee | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2022-05-06